Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research

• Ajinkya Pawar,
• Sebastian Schneeweiss,
• Jessica M Franklin,
• Xin Tong,
• Mary G George,
• Lee H Schwamm,
• Helen Mogun,
• Elisabetta Patorno,
• Lidia M V R Moura

Affiliations

Ajinkya Pawar

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women`s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Sebastian Schneeweiss

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women`s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Jessica M Franklin

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women`s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Xin Tong

Division for Heart Disease and Stroke Prevention, NCCDPHP, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Mary G George

Division for Heart Disease and Stroke Prevention, NCCDPHP, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Lee H Schwamm

Fireman Vascular Center and Stroke Division, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Helen Mogun

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women`s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Elisabetta Patorno

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women`s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Lidia M V R Moura

Epilepsy and Neurophysiology Division, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA